VIA Medical Corp. Announces Agreement With Alliance Pharmaceutical Corp. For Development Of RODA.SAN DIEGO--(BUSINESS WIRE)--Oct. 20, 1997--VIA Medical Corp. Monday announced that it has entered into an agreement with Alliance Pharmaceutical Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :ALLP ALLP Aldo Leopold Leadership Program ) to co-develop RODA RODA Regardless of Destination Airport , a Real-time Oxygen Dynamics Analyzer. RODA is being developed as a minimally invasive device to provide online monitoring of the cardiovascular and oxygenation oxygenation /ox·y·gen·a·tion/ (ok?si-je-na´shun) 1. the act or process of adding oxygen. 2. the result of having oxygen added. status of surgical patients. The information obtained from RODA is expected to assist physicians in making decisions regarding potential interventions such as blood transfusions and drug therapies. RODA combines VIA's Blood Gas and Chemistry Monitor, a device that measures blood gas and chemistry parameter ex-vivo, with Alliance's software technology, OxyFlow. The Blood Gas and Chemistry Monitor is being exhibited today at the 1997 Annual Meeting of the American Society of Anesthesiologists The American Society of Anesthesiologists (ASA) is an association of physicians (primarily anesthesiologists) whose stated goal is to raise and maintain the standards of the medical practice of anesthesiology and improve the care of the patient. in San Diego. Representatives from both companies will be available at the meeting to discuss the development of RODA. RODA would display the general hemodynamic he·mo·dy·nam·ics n. (used with a sing. verb) The study of the forces involved in the circulation of blood. he status of the patient, as well as beat-to-beat assessment of cardiac output cardiac output n. Abbr. CO The volume of blood pumped from the right or left ventricle in one minute. It is equal to the stroke volume multiplied by the heart rate. and mixed venous blood venous blood n. Abbr. v Blood that has passed through the capillaries of various tissues other than the lungs, is found in the veins, in the right chambers of the heart, and in pulmonary arteries, and is usually dark red as a result of a oxygenation, which are currently acquired from more invasive pulmonary artery catheters. Alliance has completed a pilot clinical study in Europe to assess the oxygen dynamics software, and an early-stage clinical study is currently being conducted in the United States. The development of RODA demonstrates a potential new use of VIA's automation and electrode technologies. VIA's partnership with Alliance, a public company with extensive knowledge and experience regarding tissue oxygenation, supports VIA's blood analysis expertise. "We look forward to this collaboration with Alliance Pharmaceutical in bringing to market an advanced monitoring system that complements both companies' focus on the critically ill patient in surgery and the ICU/CCU setting," said Randall Whitfield, president and chief executive officer of VIA. "RODA could be the first minimally invasive device to obtain online cardiovascular and oxygen status of patients," said Duane Roth, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Alliance. "The development of RODA will benefit from VIA's experience with the design and manufacturing of its blood monitor." VIA is a medical device company that has made a fundamental advance in the field of critical care medicine; a patient-attached monitor for automated measurement of blood chemistries. VIA's monitoring system, including blood gases, electrolytes, glucose and hematocrit Hematocrit Definition The hematocrit measures how much space in the blood is occupied by red blood cells. It is useful when evaluating a person for anemia. Purpose Blood is made up of red and white blood cells, and plasma. , uses a proprietary ex-vivo approach to provide seamless and near-continuous blood chemistry information. The VIA system provides immediate results at the point of care while eliminating sample-related blood loss and significantly reducing both blood handling and labor by the clinician. Alliance is a pharmaceutical research and development company focusing on transforming novel scientific discoveries into innovative drug products. Alliance has three products in clinical development: Oxygent (perflubron emulsion), a temporary oxygen carrier for surgical and other patients; LiquiVent, an intrapulmonary agent to reduce a patient's exposure to the harmful effects of conventional mechanical ventilation; and Imagent US, an intravenous contrast agent for enhancement of ultrasound images. These products are being co-developed with Johnson & Johnson, Hoechst Marion Roussel and Schering AG, Germany, respectively. CONTACT: VIA Medical Corp., San Diego Dave Voris, 619/793-3300 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion